• LMO2–LDB1 Signaling in Acute Myeloid Leukemia

  2026-10-08

  A 2023 study identifies an LMO2/LDB1 protein complex as a functional contributor to AML-cell proliferation and survival, integrating perturbation, protein-interaction, transcriptomic, and chromatin evidence. The findings support a mechanistic model for AML biology, while the cell-line and model-system scope limits direct clinical translation.

• NADH as a Redox Lens for Mechanistic Research

  2026-10-08

  NADH is more than an electron donor: it is an interpretive lens for connecting cellular energy metabolism, mitochondrial function, and disease biology. This article explains how to evaluate NADH-centered evidence, using the catalpol–osteoporosis study to distinguish association, mechanism, and translational relevance.

• 5-Methoxy-UTP: Evidence and Research Context

  2026-10-07

  5-Methoxy-UTP is a cataloged modified uridine triphosphate, but the supplied product record does not establish a product-specific biological mechanism. The strongest supplied evidence concerns COMET, a transformer model for predicting lipid nanoparticle formulation performance rather than the activity of this nucleotide.

• 7ACC2 in Cancer Metabolism: Evidence and Limits

  2026-10-07

  7ACC2 is a carboxycoumarin compound described as a monocarboxylate transporter 1 inhibitor and lactate transport inhibitor. This overview separates supplier-reported pharmacology from the peer-reviewed findings of Xiao et al. on the CH25H–25-hydroxycholesterol axis in immunosuppressive macrophages, and explains where connections between tumor metabolism and immune regulation remain hypothetical.

• Hematoxylin and Eosin Staining Kit K1142

  2026-10-06

  APExBIO’s K1142 H&E staining kit is a research-use reagent set described for visualizing cellular and tissue morphology in tissue sections and cytological preparations. No matched paper evidence was provided.

• MLKL Polymerization and Lysosomal Permeabilization

  2026-10-06

  A 2024 Cell Death & Differentiation study identifies MLKL polymerization-induced lysosomal membrane permeabilization as a mechanistic step in necroptosis. Its findings connect activated MLKL at lysosomal membranes with cathepsin B release and provide a framework for interpreting lysosomal protease involvement in regulated cell death.

• Superoxide Dismutase Assay Kit Overview

  2026-10-05

  APExBIO’s K2035 Superoxide Dismutase Activity Assay Kit is a research-use colorimetric assay for estimating SOD activity. No matched paper evidence was provided, so independent validation, performance claims, and disease-specific applicability cannot be assessed.

• Protease Inhibitor Cocktail: Product Overview

  2026-10-05

  APExBIO’s K1010 is an EDTA-free 100X protease inhibitor mixture in DMSO. The supplied information supports its documented identity and conceptual role in limiting endogenous proteolysis, but provides no matched paper evidence for performance or assay compatibility.

• Cyanine 3 Tyramide in Comparative Neurobiology

  2026-10-04

  Cyanine 3 Tyramide can support sensitive spatial analysis of gene expression across mammalian brain regions. This article explains how Tyramide Signal Amplification strengthens comparative neurobiology while clarifying what fluorescence can—and cannot—establish about conserved claustrum organization.

• Dual Luciferase Assay System: From Signal to Mechanism

  2026-10-03

  The Dual Luciferase Reporter Gene System can distinguish promoter activity from normalization effects in gene expression studies. This article connects dual-reporter interpretation with the 2026 tomato aluminium-tolerance study, highlighting both the system’s value and its biological limits.

• Protease Inhibitor Cocktail for MS Workflows

  2026-10-02

  Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) helps limit endogenous proteolysis during cell and tissue protein extraction while avoiding AEBSF in mass spectrometry workflows. It is intended for lysate and biochemical sample preparation, not as a validated live-cell treatment or a complete metalloprotease and phosphatase inhibitor system.

• MYC2-LBD40/42-CRL3BPM4 Tomato Defense

  2026-10-01

  The reference study identifies a MYC2–LBD40/42–CRL3BPM4 regulatory module that calibrates tomato resistance to Botrytis cinerea rather than simply switching immunity on or off. Its findings connect transcriptional repression, targeted protein degradation, genetic epistasis, and growth–defense allocation, providing a mechanistic framework for studying inducible plant immunity.

• Doxycycline in Reliable Cell Viability Workflows

  2026-10-01

  Learn how Doxycycline (SKU BA1003) can be integrated into reproducible cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay design, solvent handling, interpretation, and evidence-based product selection.

• UK-5099 for Mitochondrial Immunometabolism

  2026-09-30

  Use UK-5099, also called PF-1005023, to test how mitochondrial pyruvate entry shapes cellular energy balance and immune-cell function. This practical framework combines standardized whole-blood stimulation with orthogonal bioenergetic, cytokine, insulin-secretion, and glucose-regulation readouts.

• Berberine, RXRα/PPARγ, and SASP in Atherosclerosis

  2026-09-30

  A 2025 study identifies an RXRα/PPARγ/NEDD4 axis linking berberine treatment to reduced SASP-associated inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of Smart-seq profiling, molecular validation, and macrophage-specific RXRα knockdown provides a useful framework for testing how nuclear receptor signaling controls inflammatory aging.

539 records 1/36 page Next 12345 下5页 Last page